Cargando…

Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning

The Ki‐67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki‐67 PI requires calculation of Ki‐67‐positive and Ki‐67‐negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning‐based Ki‐67 PI alg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vesterinen, Tiina, Säilä, Jenni, Blom, Sami, Pennanen, Mirkka, Leijon, Helena, Arola, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299468/ https://www.ncbi.nlm.nih.gov/pubmed/34741788 http://dx.doi.org/10.1111/apm.13190

Ejemplares similares

Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung
por: Liu, Sandy Z, et al.
Publicado: (2014)

Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors
por: Wang, Hai-Yue, et al.
Publicado: (2019)

PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma–paraganglioma origin
por: Remes, Satu Maria, et al.
Publicado: (2020)

Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study
por: Shi, Huiying, et al.
Publicado: (2018)

piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
por: Geread, Rokshana Stephny, et al.
Publicado: (2020)

Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?
por: Patané, Ana Karina, et al.
Publicado: (2021)

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors
por: van Adrichem, R C S, et al.
Publicado: (2013)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
por: Fulawka, Lukasz, et al.
Publicado: (2022)

Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast
por: SUCIU, CRISTIAN, et al.
Publicado: (2014)

IHC Color Histograms for Unsupervised Ki67 Proliferation Index Calculation
por: Geread, Rokshana S., et al.
Publicado: (2019)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
por: Fikri, AS Fathinul, et al.
Publicado: (2015)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
por: Jeong, Tae-Dong, et al.
Publicado: (2016)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
por: Deligönül, Adem, et al.
Publicado: (2021)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Optimal settings and clinical validation for automated Ki67 calculation in neuroendocrine tumors with open source informatics (QuPath)
por: Pai, Rima, et al.
Publicado: (2022)

Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis
por: Kim, Bohyun, et al.
Publicado: (2019)

Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future
por: La Rosa, Stefano
Publicado: (2023)

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
por: Pascale, Mariarosa, et al.
Publicado: (2016)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

The cell proliferation antigen Ki-67 organises heterochromatin
por: Sobecki, Michal, et al.
Publicado: (2016)

HSP90 expression is associated with outcome in pulmonary carcinoid tumor patients
por: Niinimäki, Jenni, et al.
Publicado: (2023)

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
por: Tang, Lirui, et al.
Publicado: (2022)

Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma
por: Yao, Rong, et al.
Publicado: (2023)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life
por: Faggiano, Antongiulio, et al.
Publicado: (2015)

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021)

Correlation of Somatostatin Receptor 1–5 Expression, [(68)Ga]Ga-DOTANOC, [(18)F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms
por: Majala, Susanna, et al.
Publicado: (2021)

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer
por: Konsti, Juho, et al.
Publicado: (2011)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas
por: Menger, Richard, et al.
Publicado: (2017)

Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas
por: Ahmed, Shatha Th, et al.
Publicado: (2018)

A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer
por: Zhong, Fangfang, et al.
Publicado: (2016)

ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67
por: Nieveen van Dijkum, Els J. M.
Publicado: (2018)

Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades
por: Simbolo, Michele, et al.
Publicado: (2021)

Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer
por: Ishibashi, Naoya, et al.
Publicado: (2017)

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas
por: Duregon, Eleonora, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f3dqfhu2llu98qhg46r1s6f5qg